Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2012-06-22
Target enrollment:
Participant gender:
Summary
The objective of this clinical investigation is to determine the most effective drug
concentration(s) of BOL-303259-X in the reduction of IOP in order to support further clinical
development of an appropriate dose with regard to efficacy, and ocular and systemic safety.